---
title: A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced
  Adenoid Cystic Carcinoma and Other Tumors
date: '2023-09-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37712875/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230916180929&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: CB-103 had a manageable safety profile and biological activity
  but limited clinical antitumor activity as monotherapy in this first-in-human ...'
disable_comments: true
---
CONCLUSIONS: CB-103 had a manageable safety profile and biological activity but limited clinical antitumor activity as monotherapy in this first-in-human ...